Best GLP-1 Providers in Missouri (2026)

See by medication

Looking for a specific GLP-1? Browse Missouri providers by drug.

About GLP-1s in Missouri

Missouri permits telehealth GLP-1 prescribing. MO HealthNet Medicaid covers GLP-1s only for type 2 diabetes.

• •Missouri's adult obesity rate is 35.0%
• •MO HealthNet Medicaid restricts GLP-1 coverage to diabetes
• •Compounded semaglutide is widely available via telehealth

Top Cities for GLP-1 Treatment in Missouri

Telehealth providers ship to all Missouri addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Missouri GLP-1 clinic directory →

GLP-1 Care Access in Missouri: The Numbers

Missouri has 515 NPI-registered in-person weight-management clinics across 75 cities — 16 with an obesity-medicine taxonomy, 272 endocrinology, and 240 bariatric — alongside 97 telehealth programs that ship to Missouri addresses. The cheapest verified ongoing compounded semaglutide price available to Missouri residents is $79/mo (tirzepatide: $97/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in Missouri

In Q1 2026, Missouri Medicaid reimbursed approximately $121,205,304 across 116,884 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in Missouri cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $189/mo.

For the exact criteria, drug list, and appeal process, read our Missouri Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Missouri

According to CDC data, 35% of Missouri adults have obesity (BMI of 30 or higher). This places Missouri at #13 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Missouri residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions